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The effects of a novel polypeptide, pancreatic spasmolytic polypeptide (PSP) on a colon carcinoma cell line (HCT 116) 
were examined. PSP stimulated the incorporation of PHlthymidine into HCT 116 cells as well as cell proliferation in 
a dose-dependent manner. Maximal increase in PHlthymidine incorporation of 50-6Oq6 occurred at 3300 PM PSP. The 
VIP-mediated-incrcas in CAMP levels was reduced by PSP at > 1 PM concentrations. PSP is highly homologous to the 
estrogen-induced pS2 protein in MCF-7 breast cancer cells. We find that PSP also enhanced PH]thymidine incorporation 
in MCF-7 cells. These findings indicate for the first time that PSP has growth stimulatory properties. 
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. INTRODUCTION 
Pancreatic spasmolytic polypeptide (PSP, 
1700 Da) was first isolated from porcine pan- 
creatic extracts as a novel peptide present in large 
amounts in a side-fraction from the production of 
porcine insulin [ 11. Purified PSP has been shown to 
inhibit intestinal motility and block gastrin- 
induced gastric acid secretion [2]. The high concen- 
tration of PSP in pancreatic juice after stimulation 
with secretin and/or pancreozymin [3], its extraor- 
dinary stability against proteolytic degradation [I], 
and the presence of PSP receptors on intestinal 
epithelial cells [4,5] suggest a unique, intraluminal 
physiological mode of action for PSP. 
PSP displays a high degree of homology to the 
pS2 protein, an abundant estrogen-induced protein 
of unknown function, secreted by MCF-7 human 
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breast cancer cell line [6-91. Similar to PSP [lo], 
pS2 [l I] has a high number of cysteine residues 
whose arrangement bears resemblance to those in 
insulin-like growth factors suggesting a possible 
growth factor activity for these peptides [7,11,12]. 
Also, a novel secretory protein expressed in frog 
skin, which is known to be a rich source of a variety 
of physiologically active peptides, is highly 
homologous to PSP [ 131. In this study we have ex- 
amined the effect of PSP on the growth of cultured 
human colon carcinoma cells (HCT 116) and on 
MCF-7 breast tumor cells. 
2. MATERIALS AND METHODS 
Porcine PSP was purified as previously described [l]. HCT 
116 human colon carcinoma cells were established in culture as 
described previously [14]. HCT 116 cells have been adapted to 
growth in serum-free medium which was McCoy’s 5A contain- 
ing twice the normal concentration of sodium pyruvate, 
vitamins and amino acids. Also added are transferrin (4 pg/ml), 
insulin 20 &ml), EGF (10 ng/ml), sodium selenite (0.4 nM), 
hydrocortisone (2 Fg/ml) and triiodothyronine (0.4 nM). 
MCF-7 human breast cancer cells were obtained from Dr 
George Todaro (Seattle, USA) and maintained in McCoy’s 5A 
medium supplemented with 10% fetal bovine serum (FBS). 
In the [3H]thymidine incorporation assay, 4 h prior to 
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harvest, [‘Hlthymidine (Amersham, spec. act. 60 Ci/mmol, 
0.5 &i or 1 &i/well as indicated) was added to each well in a 
24-well plate. At the time of harvest, conditioned medium was 
aspirated and 500 ,uI of 10% TCA was added. After 10 min. the 
TCA solution was removed, cells solubilized in 5OOrl of 2 N 
NaOH which was then transferred to 10 ml scintillation cocktail 
and counted in a Beckman scintillation counter. 
To determine CAMP levels HCT 116 cells were grown in 
75 cm2 flasks in serum-free, growth-factor supplemented 
medium (see above). At late log phase of growth cells were 
harvested using Ca’ + , Mg2 + -free Hanks balanced salt solution 
containing 6 mM EDTA. Cells were spun down, washed once in 
incubation buffer (1 mg/ml BSA, 1 mM dithiothreitol, 1 mM 
theophylline, Tris-HCl, pH 7.5) and then enumerated using a 
hemocytometer. Viability of cells as determined by trypan blue 
exclusion was > 98%. Reaction mixture of total volume 100 ~1 
contained 40 /l of cell suspension (0.6 x lo6 cells), 30 pl PSP 
and/or 3011 VIP (as indicated) in incubation buffer. After 
15 min, the reaction was stopped and CAMP determined using 
the Amersham CAMP assay kit as described previously [ 151. 
Statistical analysis was done by paired Students’ t-test. 
Designations are * for P<O.O5 and ** for P<O.O25. 
3. RESULTS 
3. I. Stimulation of pH]thymidine incorporation 
by PSP 
PSP enhanced [3H]thymidine incorporation into 
HCT 116 colon carcinoma cells in a dose- 
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Fig. 1. Increased [3H]thymidine-incorporation induced by PSP 
in cultured colon carcinoma cells. HCT 116 cells were plated in 
triplicate at 1 x 104 cells/well in 24well plates. 2 days later 
when cells were 5060% confluent, conditioned medium was 
removed and PSP was added to McCoy’s SA medium (without 
any other growth factor) at the indicated concentrations. Cells 
were harvested 48 h later. 4 h prior to harvest 1 &i [‘HI- 
thymidine was added per well. Values shown are mean f SD of 
Fig.2. Increased [‘Hlthymidine incorporation in breast car- 
cinoma cells by PSP. MCF-7 cells were plated at 2 x 104 
cells/well in 10% FBS-supplemented McCoy’s SA medium. 
After 3 days when cells were nearly confluent, the growth 
medium was changed to McCoy’s 5A medium (no serum). After 
24 h starvation cells were exposed to PSP at the indicated con- 
centrations in fresh McCoy’s 5A medium. Cells were harvested 
24 h later. 4 h prior to the harvest 0.5 pCi [‘H]thymidine/well 
was added. Mean f SD of triplicate wells are given. Amount of 
[sH]thymidine incorporated by control’ cultures was 39.7 x 
10’ f 1.2 x lo3 cpm. Experiments were repeated three times 
4 experiments. with similar results. 
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dependent manner (fig. 1). Stimulation could be 
observed within 48 h of treatment at low 
nanomolar concentrations of PSP with a maximal 
increase of between 50 and 60% over control oc- 
curring in the 3-300 PM range. PSP also increased 
the cell number in a dose-dependent manner with a 
maximal increase of 60% over untreated control 
cultures at a concentration of 0.3 PM PSP (not 
shown). 
Breat tumor cells MCF-7 also responded to PSP 
with increased [3H]thymidine incorporation (fig. 
2). About 20% stimulation was observed at 3 nM 
PSP and a maximal increase of 50-60% at 
0.03-3 ,uM PSP. 
3.2. Effect of PSP on CAMP levels in colon 
tumor cells 
PSP at concentrations higher than 10 ,uM has 
been shown to reduce basal as well as VIP- 
stimulated CAMP levels in normal rat intestinal 
mucosal cells [4]. We therefore tested possible 
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Fig.3. Effect of PSP and VIP on CAMP levels in HCT 116 cells. 
Levels of CAMP after incubation with PSP alone (0) or PSP 
with 0.3 PM VIP (m). Mean f SD of three separate xperiments 
are indicated. Levels of CAMP shown are amount of CAMP 
formed/6 x ld cells/l5 min (* significantly different from 
0.3 PM VIP stimulated CAMP level). 
modulation of CAMP levels in colon tumor cells by 
PSP (fig. 3). There was no significant effect on 
basal CAMP levels up to 3OOpM PSP. VIP in- 
creases CAMP levels in a number of colon tumor 
cell lines [16,17]. As seen in fig. 4, 0.3 PM VIP 
caused a 5-6-fold increase in CAMP levels in HCT 
116 cells. PSP at concentrations higher than 1 ,LJM 
significantly reduced the VIP-mediated increase, in 
agreement with results obtained with normal in- 
testinal cells [4]. This effect of PSP is probably not 
due to inhibition of VIP binding to its cell surface 
receptors since PSP did not block ‘251-VIP binding 
to normal intestinal cell membranes [4]. Also, VIP 
did not affect receptor binding of ‘*‘I-PSP [4]. 
4. DISCUSSION 
This is the first report, to our knowledge, of 
growth stimulatory effects of PSP. The colon 
tumor cell line (HCT 116) as well as the breast 
cancer cell line (MCF-7) responded to PSP with in- 
creased [3H]thymidine incorporation. In both cell 
lines a maximal increase in [3H]thymidine incor- 
poration of 50-609’0 was observed, the half- 
maximal concentration being 500 nM for HCT 116 
cells and lower (5 nM) for MCF-7 cells. Both these 
EGO values are close to the IC50 value of 100 nM 
for ‘251-PSP binding to normal rat intestinal 
mucosal cells [4,5]. 
The proliferation of colon tumor cells has been 
shown to be inhibited by agents that enhance in- 
tracellular CAMP levels such as dibutyryl CAMP, 
forskolin, theophylline and VIP [17]. Also, the 
CAMP content of human colon carcinomas has 
been shown to be lower than that of the adjacent 
normal mucosa [ 181. Therefore, the suppression of 
VIP-stimulated CAMP levels by PSP in HCT 116 
cells may bear a causal relationship with stimula- 
tion of cell proliferation. Experiments designed to 
determine synthesis of PSP-like peptides by colon 
tumor cells need to be done in order to determine a 
possible role for such compounds in the etiology of 
colon cancer. In this regard it is of interest hat the 
pS2 protein which displays a high degree of 
homology to PSP was recently shown to be ex- 
pressed and secreted by normal human stomach 
cells, but not by several other normal tissues ex- 
amined including colon [12]. 
The lack of availability of the pS2 protein has 
hampered progress toward elucidation of its 
physiological function 1121. The growth stimulato- 
ry effect of PSP on MCF-7 cells reported herein 
could very likely be due to cross-reaction with the 
pS2 receptor. Further studies with PSP may there- 
fore help in understanding the role of pS2 in the 
mechanism of action of estrogen in breast cancer. 
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